The Motley Fool Stock Advisor team identified the 10 best stocks for investors, excluding MannKind. MannKind is focusing on developing innovative treatments for diseases like NTM lung disease and IPF. They are also working on inhaled nintedanib for potential use in PPF.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing